Geographic patterns of Plasmodium falciparum drug resistance distinguished by differential responses to amodiaquine and chloroquine
about
Challenges of drug-resistant malariaAntimalarial drug resistance: An overviewAntimalarial efficacy of piperaquine-based antimalarial combination therapies: facts and uncertaintiesStructural polymorphism in the promoter ofpfmrp2confersPlasmodium falciparumtolerance to quinoline drugsA HECT ubiquitin-protein ligase as a novel candidate gene for altered quinine and quinidine responses in Plasmodium falciparumPfCRT and its role in antimalarial drug resistanceA genome wide association study of Plasmodium falciparum susceptibility to 22 antimalarial drugs in KenyaPlasmodium falciparum drug resistance in AngolaMolecular evidence of increased resistance to anti-folate drugs in Plasmodium falciparum in North-East India: a signal for potential failure of artemisinin plus sulphadoxine-pyrimethamine combination therapyTemporal trends in prevalence of Plasmodium falciparum drug resistance alleles over two decades of changing antimalarial policy in coastal KenyaIdentification of a mutant PfCRT-mediated chloroquine tolerance phenotype in Plasmodium falciparumChloroquine clinical failures in P. falciparum malaria are associated with mutant Pfmdr-1, not Pfcrt in MadagascarPfMDR1: mechanisms of transport modulation by functional polymorphismsPyronaridine-artesunate versus chloroquine in patients with acute Plasmodium vivax malaria: a randomized, double-blind, non-inferiority trialA process similar to autophagy is associated with cytocidal chloroquine resistance in Plasmodium falciparumMolecular Mechanisms for Drug Hypersensitivity Induced by the Malaria Parasite's Chloroquine Resistance TransporterEvolution of Fitness Cost-Neutral Mutant PfCRT Conferring P. falciparum 4-Aminoquinoline Drug Resistance Is Accompanied by Altered Parasite Metabolism and Digestive Vacuole PhysiologyAlternatively spliced transcripts and novel pseudogenes of the Plasmodium falciparum resistance-associated locus pfcrt detected in East African malaria patientsMultiple drugs compete for transport via the Plasmodium falciparum chloroquine resistance transporter at distinct but interdependent sitesThe effect of dosing strategies on the therapeutic efficacy of artesunate-amodiaquine for uncomplicated malaria: a meta-analysis of individual patient dataA Variant PfCRT Isoform Can Contribute to Plasmodium falciparum Resistance to the First-Line Partner Drug PiperaquineDiverse mutational pathways converge on saturable chloroquine transport via the malaria parasite's chloroquine resistance transporterAnalysis of malaria parasite phenotypes using experimental genetic crosses of Plasmodium falciparum.Use of proscribed chloroquine is associated with an increased risk of pfcrt T76 mutation in some parts of Ghana.Progressive increase in point mutations associates chloroquine resistance: Even after withdrawal of chloroquine use in IndiaProtein-based signatures of functional evolution in Plasmodium falciparum.Profile of Thomas E. WellemsRapid evolution of fluoroquinolone-resistant Escherichia coli in Nigeria is temporally associated with fluoroquinolone useDNA repair mechanisms and their biological roles in the malaria parasite Plasmodium falciparum.Double mutation in the pfmdr1 gene is associated with emergence of chloroquine-resistant Plasmodium falciparum malaria in Eastern IndiaProtecting the malaria drug arsenal: halting the rise and spread of amodiaquine resistance by monitoring the PfCRT SVMNT typeEfficacy of artemisinin-based combination treatments of uncomplicated falciparum malaria in under-five-year-old Nigerian children.Return of chloroquine-sensitive Plasmodium falciparum parasites and emergence of chloroquine-resistant Plasmodium vivax in Ethiopia.Molecular assessment of Plasmodium falciparum resistance to antimalarial drugs in Papua New Guinea using an extended ligase detection reaction fluorescent microsphere assay.Malaria biology and disease pathogenesis: insights for new treatments.Role of Pfmdr1 in in vitro Plasmodium falciparum susceptibility to chloroquine, quinine, monodesethylamodiaquine, mefloquine, lumefantrine, and dihydroartemisininEvidence that mutant PfCRT facilitates the transmission to mosquitoes of chloroquine-treated Plasmodium gametocytesDifferential drug efflux or accumulation does not explain variation in the chloroquine response of Plasmodium falciparum strains expressing the same isoform of mutant PfCRT.Plasmodium falciparum resistance to cytocidal versus cytostatic effects of chloroquine.Assessment of molecular markers for anti-malarial drug resistance after the introduction and scale-up of malaria control interventions in western Kenya.
P2860
Q21032482-9B5F2D10-04E1-4F76-9073-ADEAAD74BE2CQ26753085-9061C99D-52F7-4FE1-A1A3-E0246992C763Q26866187-4C638234-3030-4997-B26C-831B304E93B0Q27861940-505F17AC-42B2-4EB8-88FA-CD7752D9FFAEQ27861949-EEAD8D2B-D1DF-44C2-A6EC-CC82DC4189FCQ27861957-FE09FB19-5894-4778-B1AF-FA93EB5087B5Q28031418-2D39105C-2FA2-4D72-B1A7-9631A413048DQ28075079-8A77E7B1-53F7-4D86-8F1C-4A934515D8AEQ28125911-956BAAF7-809C-469C-863D-F4D47693912FQ28125914-56B827FE-2B76-4A07-AB13-1ABFFC1E8C19Q28473923-6075C34E-CBCD-4A50-B445-5E4C579F693DQ28475757-F52A5536-9B26-4346-ADD0-1AF409DD3410Q28476753-005EE904-E0D8-4B65-8B33-EA14D46D89BCQ28476754-D6230BA3-0636-4F41-BF7C-06B018970202Q28535307-560324B4-D5FA-4AF8-8595-B23B6ABAE195Q28552775-BF66FBB9-4436-4396-9C77-E6A4330BAD7CQ28553454-675EC662-D1C4-47CB-8E4C-BD3C52BA488FQ28649722-1406F391-E499-4533-A478-DBBAC97F4DD6Q30041687-A3BEE6AC-9667-487F-B58D-45D3FBE93C45Q30936416-C194F05C-DFD0-4581-90D8-1E707E38F5B6Q33654512-C28A13E8-1AD5-479C-8B6D-98953194AC4CQ33674606-FDD3727E-1640-4033-BAF7-86AFE0C878FCQ33691907-57DB900D-4ECA-44A6-A480-01462B0485B0Q33870057-38BD651B-1BAC-4208-91EF-87D5CF637B25Q33889755-6517F083-EA59-4987-9AC5-15A45EF58FBBQ34019480-38D59C82-56EB-4C5C-BB4F-CBE45A10BA2AQ34068465-DD6CD2E9-6D46-4677-8235-882CECC4F21CQ34068877-4DEE3BF3-4B23-407A-A95D-AACCEF41F679Q34297803-A712DA09-3607-47B5-BC93-ACEB67A5C560Q34298884-A1818058-5DC6-4DFE-87E3-EE755C8BC1BFQ34485979-0F4E6A43-5314-4514-9025-FF858A3E9D79Q34496205-DC1E3D2D-9C8E-4B33-B27C-A035389087ECQ34504371-AF1B1001-A1EB-44C4-A0F3-14AD9BD3533DQ34529101-DB033180-A24D-4DEA-8896-7B239DBBB2A9Q34579700-026BCB23-CE5A-43E2-9031-A390744F2D5DQ34597550-8E0BD76B-A122-486B-936C-0672F78ACC03Q34763527-8CE8CCD8-B16B-4024-8D91-159095997D71Q34932500-9A5F092C-977F-48FF-97F5-3474E22A97A3Q35004539-BA5D962F-4A54-4086-B17D-375E77DF0DF5Q35092092-FEE3F751-EFB9-48C9-9BFF-4C86C43FE53F
P2860
Geographic patterns of Plasmodium falciparum drug resistance distinguished by differential responses to amodiaquine and chloroquine
description
2009 nî lūn-bûn
@nan
2009 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
2009 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
2009年の論文
@ja
2009年論文
@yue
2009年論文
@zh-hant
2009年論文
@zh-hk
2009年論文
@zh-mo
2009年論文
@zh-tw
2009年论文
@wuu
name
Geographic patterns of Plasmod ...... to amodiaquine and chloroquine
@ast
Geographic patterns of Plasmod ...... to amodiaquine and chloroquine
@en
type
label
Geographic patterns of Plasmod ...... to amodiaquine and chloroquine
@ast
Geographic patterns of Plasmod ...... to amodiaquine and chloroquine
@en
prefLabel
Geographic patterns of Plasmod ...... to amodiaquine and chloroquine
@ast
Geographic patterns of Plasmod ...... to amodiaquine and chloroquine
@en
P2093
P2860
P50
P921
P3181
P356
P1476
Geographic patterns of Plasmod ...... to amodiaquine and chloroquine
@en
P2093
Juliana Martha Sá
Karen Hayton
Pascal Ringwald
Thomas E Wellems
P2860
P304
18883-18889
P3181
P356
10.1073/PNAS.0911317106
P407
P577
2009-11-02T00:00:00Z